Investing.com - 4D Molecular (NASDAQ: FDMT) reported third quarter EPS of $-0.24, $0.37 better than the analyst estimate of $-0.61. Revenue for the quarter came in at $20.2M versus the consensus estimate of $9.18M.
4D Molecular's stock price closed at $10.50. It is down -37.24% in the last 3 months and up 7.91% in the last 12 months.
4D Molecular saw 5 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See 4D Molecular's stock price’s past reactions to earnings here.
According to InvestingPro, 4D Molecular's Financial Health score is "fair performance".
Check out 4D Molecular's recent earnings performance, and 4D Molecular's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar